US 11518812
Monoclonal antibodies against HER2 epitope and methods of use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11518812 (Monoclonal antibodies against HER2 epitope and methods of use thereof) held by Mersana Therapeutics, Inc. expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mersana Therapeutics, Inc.
- Grant date
- Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/08, A61K45/06